US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
US5010175A
(en)
|
1988-05-02 |
1991-04-23 |
The Regents Of The University Of California |
General method for producing and selecting peptides with specific properties
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
IE66205B1
(en)
|
1990-06-14 |
1995-12-13 |
Paul A Bartlett |
Polypeptide analogs
|
US5650489A
(en)
|
1990-07-02 |
1997-07-22 |
The Arizona Board Of Regents |
Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
|
US5384253A
(en)
|
1990-12-28 |
1995-01-24 |
Dekalb Genetics Corporation |
Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
|
AU2515992A
(en)
|
1991-08-20 |
1993-03-16 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
WO1993005021A1
(en)
|
1991-09-06 |
1993-03-18 |
Yoshitomi Pharmaceutical Industries, Ltd. |
4-amino(alkyl)cyclohexane-1-carboxamide compound and use thereof
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
US5702932A
(en)
|
1992-07-20 |
1997-12-30 |
University Of Florida |
Microinjection methods to transform arthropods with exogenous DNA
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
EP0710283A4
(en)
|
1993-07-22 |
1997-07-02 |
Merck & Co Inc |
THE EXPRESSION OF HUMAN INTERLEUKIN-1-g (b) IN A TRANSGENIC ANIMAL
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
US5593853A
(en)
|
1994-02-09 |
1997-01-14 |
Martek Corporation |
Generation and screening of synthetic drug libraries
|
US5539083A
(en)
|
1994-02-23 |
1996-07-23 |
Isis Pharmaceuticals, Inc. |
Peptide nucleic acid combinatorial libraries and improved methods of synthesis
|
US5656610A
(en)
|
1994-06-21 |
1997-08-12 |
University Of Southern California |
Producing a protein in a mammal by injection of a DNA-sequence into the tongue
|
US5525735A
(en)
|
1994-06-22 |
1996-06-11 |
Affymax Technologies Nv |
Methods for synthesizing diverse collections of pyrrolidine compounds
|
US5549974A
(en)
|
1994-06-23 |
1996-08-27 |
Affymax Technologies Nv |
Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof
|
US5736524A
(en)
|
1994-11-14 |
1998-04-07 |
Merck & Co.,. Inc. |
Polynucleotide tuberculosis vaccine
|
US5843780A
(en)
|
1995-01-20 |
1998-12-01 |
Wisconsin Alumni Research Foundation |
Primate embryonic stem cells
|
EP2258726A1
(en)
|
1995-06-14 |
2010-12-08 |
The Regents of the University of California |
High affinity human antibodies to c-erbB-2
|
US5569588A
(en)
|
1995-08-09 |
1996-10-29 |
The Regents Of The University Of California |
Methods for drug screening
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
US5780448A
(en)
|
1995-11-07 |
1998-07-14 |
Ottawa Civic Hospital Loeb Research |
DNA-based vaccination of fish
|
GB9807935D0
(en)
|
1998-04-14 |
1998-06-10 |
Univ Edinburgh |
Lineage specific cells and progenitor cells
|
US5945100A
(en)
|
1996-07-31 |
1999-08-31 |
Fbp Corporation |
Tumor delivery vehicles
|
NZ513800A
(en)
|
1996-08-12 |
2001-09-28 |
Welfide Corp |
Treatment of diseases using Rho kinase inhibitors
|
US5981274A
(en)
|
1996-09-18 |
1999-11-09 |
Tyrrell; D. Lorne J. |
Recombinant hepatitis virus vectors
|
ES2321462T3
(es)
|
1997-05-07 |
2009-06-05 |
Pharma Mar, S.A. |
Uso de aplidina para el tratamiento de enfermedades cardiovasculares.
|
DE69839444D1
(de)
|
1997-06-13 |
2008-06-19 |
Ludwig Inst Cancer Res |
Smad 6 und dessen anwendungen
|
PT993439E
(pt)
|
1997-07-01 |
2004-12-31 |
Warner Lambert Co |
Derivados de acido 4-bromo ou 4-iodofenilaminobenzidroxamico e sua utilizacao como inibidores de mek
|
US5994624A
(en)
|
1997-10-20 |
1999-11-30 |
Cotton Incorporated |
In planta method for the production of transgenic plants
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
US20060263382A1
(en)
|
1998-06-20 |
2006-11-23 |
Richard Hotchkiss |
Membrane-permeant peptide complexes for treatment of sepsis
|
US6800790B2
(en)
|
1998-07-24 |
2004-10-05 |
Carnegie Institution Of Washington |
Method for maintenance and propagation of germline stem cells using members of the TFG-β family of growth factors
|
GB9819912D0
(en)
|
1998-09-11 |
1998-11-04 |
Univ Edinburgh |
Propagation and/or derivation of embryonic stem cells
|
DE69924641D1
(de)
|
1999-01-07 |
2005-05-12 |
Warner Lambert Company Llc Mor |
Behandlung von asthma anhand von mek-inhibitoren
|
US6703420B1
(en)
|
1999-03-19 |
2004-03-09 |
Bristol-Myers Squibb Pharma Company |
Amino-thio-acrylonitriles as MEK inhibitors
|
AU5250400A
(en)
|
1999-06-18 |
2001-01-09 |
Mitsubishi Pharma Corporation |
Osteogenesis promoters
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
WO2001017562A1
(en)
|
1999-09-02 |
2001-03-15 |
Yamanouchi Pharmaceutical Co., Ltd. |
Osteogenesis promoting agents
|
US20020142457A1
(en)
|
1999-12-28 |
2002-10-03 |
Akihiro Umezawa |
Cell having the potentiality of differentiation into cardiomyocytes
|
US6692736B2
(en)
|
2000-03-24 |
2004-02-17 |
Cell Genesys, Inc. |
Cell-specific adenovirus vectors comprising an internal ribosome entry site
|
CN1219753C
(zh)
|
2000-07-19 |
2005-09-21 |
沃尼尔·朗伯公司 |
4-碘苯氨基苯氧肟酸的氧合酯
|
CA2441492C
(en)
|
2001-03-23 |
2011-08-09 |
Bayer Corporation |
Rho-kinase inhibitors
|
DK1370552T3
(da)
|
2001-03-23 |
2007-05-07 |
Bayer Pharmaceuticals Corp |
Rho-kinase-inhibitorer
|
WO2002088346A2
(en)
|
2001-05-01 |
2002-11-07 |
National Research Council Of Canada |
A system for inducible expression in eukaryotic cells
|
US20050130144A1
(en)
|
2001-09-21 |
2005-06-16 |
Norio Nakatsuji |
Method of screening reprogramming factor, reprogramming factor screened by the method, method of using the reprogramming factor, method of differentiating undifferentiated fused cells and method of constructing cell, tissues and organs
|
SI1456380T1
(sl)
|
2001-11-02 |
2012-11-30 |
Giuliani Int Ltd |
Smad inhibitorji za zdravljenje cns bolezni
|
ES2305435T3
(es)
|
2002-01-10 |
2008-11-01 |
Bayer Healthcare Ag |
Inhibidores de la rho-quinasa.
|
WO2003062225A1
(en)
|
2002-01-23 |
2003-07-31 |
Bayer Pharmaceuticals Corporation |
Pyrimidine derivatives as rho-kinase inhibitors
|
CA2473910C
(en)
|
2002-01-23 |
2011-03-15 |
Bayer Pharmaceuticals Corporation |
Pyrimidine derivatives as rho-kinase inhibitors
|
AU2003210405A1
(en)
|
2002-03-05 |
2003-09-16 |
Artemis Pharmaceuticals Gmbh |
Inbred embryonic stem-cell derived mice
|
HUE025767T2
(en)
|
2002-03-13 |
2016-05-30 |
Array Biopharma Inc |
N3-alkylated benzimidazole derivatives as MEK inhibitors
|
AU2003220935A1
(en)
|
2002-04-03 |
2003-10-13 |
Sumitomo Pharmaceuticals Company, Limited. |
Benzamide derivatives
|
GB0210539D0
(en)
|
2002-05-08 |
2002-06-19 |
Univ Edinburgh |
Control of es cell self renewal and lineage specification, and medium therefor
|
EP1562935B1
(de)
|
2002-10-28 |
2006-09-06 |
Bayer HealthCare AG |
Heteroaryloxy-substituierte phenylaminopyrimidine als rho-kinaseinhibitoren
|
MXPA05003431A
(es)
|
2002-11-15 |
2005-07-05 |
Warner Lambert Co |
Quimioterapia de combinacion.
|
JP2006517234A
(ja)
|
2003-02-10 |
2006-07-20 |
アムジエン・インコーポレーテツド |
バニロイド受容体リガンドおよび治療におけるこれらのリガンドの使用
|
AU2003901099A0
(en)
|
2003-03-11 |
2003-03-27 |
Es Cell International Pte Ltd. |
Methods of inducing differentiation of stem cells
|
US20050075276A1
(en)
|
2003-03-14 |
2005-04-07 |
Christopher Rudd |
Use of inhibitors of glycogen synthase-3 to augment CD28 dependent -T-cell responses
|
US20070010008A1
(en)
|
2005-06-29 |
2007-01-11 |
Tissuetech, Inc. |
Ex vivo expansion of primary animal cells
|
EP1732581A4
(en)
|
2003-06-20 |
2008-06-04 |
Univ California San Diego |
POLYPEPTIDE TRANSDUCTION AND FUSOGENIC PEPTIDES
|
US7727762B2
(en)
|
2003-10-03 |
2010-06-01 |
Keiichi Fukuda |
Method of inducing the differentiation of stem cells into myocardial cells
|
JP4110324B2
(ja)
|
2003-10-15 |
2008-07-02 |
宇部興産株式会社 |
新規インダゾール誘導体
|
EP1673444A2
(en)
|
2003-10-16 |
2006-06-28 |
The University Court Of The University Of Edinburgh |
Control of es cell self-renewal and lineage specification, and medium therefor
|
AU2004293019B2
(en)
|
2003-11-19 |
2010-10-28 |
Array Biopharma Inc. |
Bicyclic inhibitors of MEK and methods of use thereof
|
AU2004291559B2
(en)
|
2003-11-19 |
2008-10-16 |
Australian Stem Cell Centre Limited |
Methods for producing blood products from pluripotent cells in cell culture
|
US20070269412A1
(en)
|
2003-12-02 |
2007-11-22 |
Celavie Biosciences, Llc |
Pluripotent cells
|
US20080275062A1
(en)
|
2004-01-30 |
2008-11-06 |
David Harold Drewry |
Chemical Compounds
|
EP1740601B1
(en)
|
2004-04-21 |
2012-12-05 |
The University of Chicago |
Myosin light chain kinase inhibitors and their use
|
KR20070083559A
(ko)
|
2004-08-13 |
2007-08-24 |
더 유니버시티 오브 죠지아 리서치 파운데이션, 인코포레이티드 |
인간 배아 줄기세포에서의 자가재생 및 분화를 위한 조성물및 방법
|
WO2006026473A2
(en)
|
2004-08-25 |
2006-03-09 |
University Of Georgia Research Foundation, Inc. |
METHODS AND COMPOSITIONS UTILIZING MYC AND GSK3ß TO MANIPULATE THE PLURIPOTENCY OF EMBRYONIC STEM CELLS
|
WO2006088867A2
(en)
|
2005-02-15 |
2006-08-24 |
Medistem Laboratories, Incorporated |
Method for expansion of stem cells
|
ES2405785T3
(es)
|
2005-05-18 |
2013-06-03 |
Array Biopharma Inc. |
Inhibidores heterocíclicos de MEK y métodos de uso de los mismos
|
AU2006275479B2
(en)
|
2005-08-01 |
2012-11-29 |
Nupotential, Inc. |
Production of reprogrammed cells with restored potential
|
US20080242594A1
(en)
|
2005-09-08 |
2008-10-02 |
Mckay Ronald D G |
Methods for Promoting Stem Cell Proliferation and Survival
|
US8217042B2
(en)
|
2005-11-11 |
2012-07-10 |
Zentaris Gmbh |
Pyridopyrazines and their use as modulators of kinases
|
CN101864392B
(zh)
|
2005-12-13 |
2016-03-23 |
国立大学法人京都大学 |
核重新编程因子
|
US20090227032A1
(en)
|
2005-12-13 |
2009-09-10 |
Kyoto University |
Nuclear reprogramming factor and induced pluripotent stem cells
|
GB0601538D0
(en)
|
2006-01-26 |
2006-03-08 |
Univ Birmingham |
Epigenetic analysis
|
WO2007088651A1
(ja)
|
2006-02-01 |
2007-08-09 |
The University Of Tokyo |
TGF-βシグナル阻害剤と抗腫瘍剤の組み合せ使用
|
US7541186B2
(en)
|
2006-02-22 |
2009-06-02 |
University Of Washington |
Method of generating human retinal progenitors from embryonic stem cells
|
US9074180B2
(en)
|
2006-03-30 |
2015-07-07 |
The University Court Of The University Of Edinburgh |
Culture medium containing kinase inhibitors, and uses thereof
|
GB0615327D0
(en)
|
2006-03-30 |
2006-09-13 |
Univ Edinburgh |
Culture medium containing kinase inhibitors and uses thereof
|
US8741643B2
(en)
|
2006-04-28 |
2014-06-03 |
Lifescan, Inc. |
Differentiation of pluripotent stem cells to definitive endoderm lineage
|
CA2650561C
(en)
|
2006-05-02 |
2014-02-25 |
Wisconsin Alumni Research Foundation |
Method of differentiating stem cells into cells of the endoderm and pancreatic lineage
|
JP2009542666A
(ja)
|
2006-06-30 |
2009-12-03 |
シェーリング コーポレイション |
P53活性を増加させる置換ピペリジンおよびその使用
|
JP4960450B2
(ja)
|
2006-07-14 |
2012-06-27 |
ノバルティス アーゲー |
Alk−5阻害剤としてのピリミジン誘導体
|
US20080020014A1
(en)
|
2006-07-19 |
2008-01-24 |
Paul Consigny |
Implantable devices containing nuclear receptor ligands for the treatment of vascular and related disorders
|
CN101563449A
(zh)
|
2006-09-22 |
2009-10-21 |
理化学研究所 |
干细胞培养基及干细胞培养方法
|
JP2008099662A
(ja)
|
2006-09-22 |
2008-05-01 |
Institute Of Physical & Chemical Research |
幹細胞の培養方法
|
GB0622395D0
(en)
|
2006-11-09 |
2006-12-20 |
Univ Cambridge Tech |
Methods relating to pluripotent cells
|
US7892830B2
(en)
|
2007-01-17 |
2011-02-22 |
Wisconsin Alumni Research Foundation |
Clonal culture of human pluripotent stem cells
|
US20100172883A1
(en)
|
2007-01-19 |
2010-07-08 |
Bruneau Benoit Gaetan |
Methods of generating cardiomyocytes
|
KR20090115142A
(ko)
|
2007-01-30 |
2009-11-04 |
유니버시티 오브 조지아 리서치 파운데이션, 인코포레이티드 |
초기 중배엽 세포,내배엽 및 중배엽 계통의 생성에 유용한 중내배엽 세포의 안정한 집단 및 다능성 유주 세포(mmc)
|
KR20090122946A
(ko)
|
2007-02-27 |
2009-12-01 |
주식회사 프로셀제약 |
줄기세포의 자가-재생을 촉진하고 분화를 억제하기 위한 세포투과성 nanog 및 oct4의 병합 용도
|
EP2131840B1
(en)
|
2007-03-07 |
2018-10-17 |
MEI Pharma, Inc. |
Combination of benzimidazole anti-cancer agent and a second anti-cancer agent
|
WO2008126932A2
(en)
|
2007-04-09 |
2008-10-23 |
Riken |
Epigenetical regulation of brain plasticity
|
CN103555654B
(zh)
|
2007-04-18 |
2016-04-20 |
哈达锡特医学研究服务及发展有限公司 |
干细胞衍生的视网膜色素上皮细胞
|
US7878210B2
(en)
|
2007-06-04 |
2011-02-01 |
Philip Morris Usa Inc. |
Cellulose acetate fiber modification
|
US8648069B2
(en)
|
2007-06-08 |
2014-02-11 |
Abbvie Inc. |
5-substituted indazoles as kinase inhibitors
|
JP2008307007A
(ja)
|
2007-06-15 |
2008-12-25 |
Bayer Schering Pharma Ag |
出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
|
US9213999B2
(en)
|
2007-06-15 |
2015-12-15 |
Kyoto University |
Providing iPSCs to a customer
|
KR20160005142A
(ko)
|
2007-06-29 |
2016-01-13 |
셀룰러 다이내믹스 인터내셔널, 인코포레이티드 |
배아줄기세포 배양을 위한 자동화 방법 및 장치
|
US20120282229A1
(en)
|
2007-08-01 |
2012-11-08 |
Christian Kannemeier |
Non-viral delivery of transcription factors that reprogram human somatic cells into a stem cell-like state
|
JP6151879B2
(ja)
|
2007-08-31 |
2017-06-21 |
ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ |
体細胞を再プログラミングすることにおけるwnt経路の刺激
|
CN101617043B
(zh)
|
2007-10-31 |
2014-03-12 |
国立大学法人京都大学 |
核重编程方法
|
US20110151447A1
(en)
|
2007-11-06 |
2011-06-23 |
Children's Medical Center Corporation |
Method to produce induced pluripotent stem (ips) cells from non-embryonic human cells
|
JP4604076B2
(ja)
|
2007-11-07 |
2010-12-22 |
国立大学法人静岡大学 |
燃料電池用電解質膜
|
US20110033931A1
(en)
|
2007-11-29 |
2011-02-10 |
Children's Hospital Of Orange County |
De-differentiation of human cells
|
WO2009067756A1
(en)
|
2007-11-30 |
2009-06-04 |
Cytomatrix Pty Ltd |
Methods of inducing pluripotency involving sox2 protein
|
EP2224940A1
(en)
|
2007-11-30 |
2010-09-08 |
Cytomatrix PTY LTD |
Methods of inducing pluripotency involving oct4 protein
|
SG188904A1
(en)
|
2008-03-17 |
2013-04-30 |
Scripps Research Inst |
Combined chemical and genetic approaches for generation of induced pluripotent stem cells
|
JP2011516042A
(ja)
|
2008-03-17 |
2011-05-26 |
へルムホルツ・ツェントルム・ミュンヘン−ドイチェス・フォルシュングスツェントルム・ヒューア・ゲズントハイト・ウント・ウムヴェルト(ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング) |
部位特異的組み換えを用いて無ベクター誘導多能性幹(iPS)細胞を作製するベクターおよびその方法
|
CN101550406B
(zh)
|
2008-04-03 |
2016-02-10 |
北京大学 |
制备多潜能干细胞的方法,试剂盒及用途
|
CA2697621C
(en)
|
2008-07-30 |
2017-01-17 |
Kyoto University |
Method of efficiently establishing induced pluripotent stem cells
|
US8298825B1
(en)
|
2008-08-25 |
2012-10-30 |
The General Hospital Corporation |
TGF-beta receptor inhibitors to enhance direct reprogramming
|
CA2907326A1
(en)
|
2008-11-04 |
2010-05-14 |
Chad Green |
Stem cell aggregate suspension compositions and methods for differentiation thereof
|
CA2745266C
(en)
|
2008-12-03 |
2018-04-10 |
Yue Xu |
Stem cell cultures
|
EP3312269A1
(en)
|
2008-12-17 |
2018-04-25 |
The Scripps Research Institute |
Generation and maintenance of stem cells
|
WO2010102267A2
(en)
|
2009-03-06 |
2010-09-10 |
Ipierian, Inc. |
Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells
|
CA2758003A1
(en)
|
2009-04-13 |
2010-10-21 |
The Regents Of The University Of California |
Methods and compositions for stem cell cultures
|
US20100303775A1
(en)
|
2009-05-27 |
2010-12-02 |
The Salk Institute For Biological Studies |
Generation of Genetically Corrected Disease-free Induced Pluripotent Stem Cells
|
WO2010137348A1
(en)
|
2009-05-29 |
2010-12-02 |
Keio University |
Method for selecting clone of induced pluripotent stem cells
|
US8524498B2
(en)
|
2009-05-29 |
2013-09-03 |
The General Hospital Corporation |
Methods and compositions for homologous recombination in human cells
|
CN103087991B
(zh)
*
|
2009-06-05 |
2018-06-12 |
富士胶片细胞动力公司 |
重编程t细胞和造血细胞的方法
|
AU2010279913B2
(en)
|
2009-08-07 |
2016-04-28 |
Kyoto University |
Method of efficiently establishing induced pluripotent stem cells
|
MX337982B
(es)
|
2009-10-16 |
2016-03-30 |
Scripps Research Inst |
Induccion de celulas pluripotentes.
|
SI2494039T1
(sl)
|
2009-10-31 |
2020-03-31 |
Genesis Technologies Limited |
Postopek reprogramiranja celic in njihova uporaba
|
WO2011056971A2
(en)
|
2009-11-04 |
2011-05-12 |
Cellular Dynamics International, Inc. |
Episomal reprogramming with chemicals
|
EP2499236B1
(en)
|
2009-11-12 |
2020-01-01 |
Technion Research & Development Foundation Ltd. |
Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
|
JP5827220B2
(ja)
*
|
2010-01-22 |
2015-12-02 |
国立大学法人京都大学 |
人工多能性幹細胞の樹立効率改善方法
|
WO2011103343A2
(en)
|
2010-02-17 |
2011-08-25 |
Biotime Inc. |
Methods for telomere length and genomic dna quality control analysis in pluripotent stem cells
|
CN102844428B
(zh)
|
2010-03-05 |
2015-09-02 |
德克萨斯心脏研究所 |
Ets2和mesp1由成纤维细胞生成心脏祖细胞
|
EP3199623B1
(en)
|
2010-03-31 |
2021-07-28 |
The Scripps Research Institute |
Reprogramming cells
|
US20110306516A1
(en)
|
2010-06-15 |
2011-12-15 |
The New York Stem Cell Foundation |
Methods for producing induced pluripotent stem cells
|
JPWO2011158852A1
(ja)
|
2010-06-15 |
2013-08-19 |
国立大学法人 東京大学 |
誘導型多能性幹細胞の製造方法
|
ES2670842T3
(es)
|
2010-06-15 |
2018-06-01 |
Cellular Dynamics International, Inc. |
Generación de células madre pluripotentes inducidas a partir de pequeños volúmenes de sangre periférica
|
JP5936218B2
(ja)
|
2010-08-04 |
2016-06-22 |
セルラー ダイナミクス インターナショナル, インコーポレイテッド |
不死化b細胞のリプログラミング
|
CA2822638C
(en)
|
2010-12-22 |
2021-02-16 |
Fate Therapeutics, Inc. |
Cell culture platform for single cell sorting and enhanced reprogramming of ipscs
|
WO2013070852A2
(en)
*
|
2011-11-08 |
2013-05-16 |
Emory University |
Compounds and compositions used to epigenetically transform cells and methods related thereto
|
AU2012347534B2
(en)
|
2011-12-08 |
2018-01-25 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
|
WO2013159103A1
(en)
*
|
2012-04-20 |
2013-10-24 |
Whitehead Institute For Biomedical Research |
Programming and reprogramming of cells
|
JP6164746B2
(ja)
|
2012-05-22 |
2017-07-19 |
国立大学法人 東京大学 |
抗原特異的t細胞の製造方法
|
US9166832B1
(en)
|
2013-10-04 |
2015-10-20 |
Altera Corporation |
Methods and apparatus for decision feedback equalization adaptation
|
AU2015227184B2
(en)
*
|
2014-03-04 |
2021-05-20 |
Fate Therapeutics, Inc. |
Improved reprogramming methods and cell culture platforms
|
JP7263005B2
(ja)
|
2015-10-16 |
2023-04-24 |
フェイト セラピューティクス,インコーポレイテッド |
基底状態の多能性の誘導及び維持に関するプラットフォーム
|
PT3371314T
(pt)
|
2015-11-04 |
2023-08-31 |
Fate Therapeutics Inc |
Modificação genómica de células pluripotentes
|